Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11
Published: Sept. 11, 2024
The effectiveness and safety of a novel class hypoglycemic medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors have not been completely established in relation to acute heart failure (AHF). Consequently, we sought compare the prognostic outcomes patients administered SGLT2 for treatment AHF.
Language: Английский
American Heart Journal, Journal Year: 2024, Volume and Issue: 277, P. 47 - 57
Published: July 31, 2024
Language: Английский
Citations
3
JACC Heart Failure, Journal Year: 2025, Volume and Issue: 13(5), P. 829 - 839
Published: May 1, 2025
Language: Английский
Citations
0
Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(15), P. 4470 - 4470
Published: July 30, 2024
Congestion and fluid retention are the hallmarks of decompensated heart failure major reason for hospitalization patients with failure. Diuretics have been used in decades, they remain backbone contemporary management Loop diuretics is preferred diuretic, it has given a class I recommendation by clinical guidelines relief congestion symptoms. Although loop virtually among all acute failure, there still very limited evidence to guide optimized use. This sharp contrast rapidly growing rest guideline-directed medical therapy calls further studies. The possess unique pharmacology pharmacokinetics that lay ground different strategies increase diuretic efficiency. However, many these approaches not evaluated randomized trials. In recent years, stepped protocolized dosing suggested superior benefits over an individual clinician-based strategy. Diuretic resistance challenge decongestion associated poor prognosis. Recently, options emerged help overcome this review, we aim provide comprehensive review use context attention its side effects, adjuncts, as well challenges future direction.
Language: Английский
Citations
2
Heart Failure Reviews, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 12, 2024
Abstract Diuresis to achieve decongestion is a central aim of therapy in patients hospitalized for acute decompensated heart failure (ADHF). While multiple approaches have been tried adequate rapidly while minimizing adverse effects, no single diuretic strategy has shown superiority, and there paucity data guidelines utilize making these decisions. Observational cohort studies associations between urine sodium excretion outcomes after hospitalization ADHF. Urine chemistries (urine ± creatinine) may guide titration during ADHF, randomized clinical trials designed compare chemistry–guided diuresis usual care. This review will summarize current literature monitoring strategies, outline evidence gaps, describe the recently completed ongoing address gaps with ADHF particular focus on utility sodium–guided strategies.
Language: Английский
Citations
2
Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11
Published: Sept. 11, 2024
The effectiveness and safety of a novel class hypoglycemic medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors have not been completely established in relation to acute heart failure (AHF). Consequently, we sought compare the prognostic outcomes patients administered SGLT2 for treatment AHF.
Language: Английский
Citations
2